Advertisement
Advertisement

TNXP

TNXP logo

Tonix Pharmaceuticals Holding Corp.

12.39
USD
Sponsored
+0.29
+2.44%
Jun 25, 11:14 UTC -4
Open

Tonix Pharmaceuticals Holding Corp. Profile

About

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Info & Links

CEO

Seth Lederman

Headquarters

200 Connell Drive, Suite 3100
Berkeley Heights, NJ 07928, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.tonixpharma.com

Auditor

EISNERAMPER LLP

Share holders

421

Employees

142

Tonix Pharmaceuticals Holding Corp. Statistics

Valuation Measures

Market Capitalization2

197.59M

Enterprise Value

12.12M

Enterprise Value/EBITDA(ttm)

-0.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

13.30

Price to Book(mrq)

0.68

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

34.06%

Operating Margin(ttm)

-946.22%

Profit Margin(ttm)

-987.78%

Return on Equity(ttm)

-60.15%

Return on Invested Capital(ttm)

-59.14%

Return on Assets(ttm)

-54.52%

Income Statement

Revenue(ttm)

17.56M

Revenue Per Share(ttm)

1.10

Gross Profit(ttm)

10.28M

EBITDA(ttm)3

-149.20M

Net Income Available to Common(ttm)

-147.39M

Diluted EPS(ttm)

-14.27

Share Statistics

Beta (5Y Monthly)

1.75

52-Week Change

-65.25%

S&P 500 52-Week Change

21.11%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

15.94M

Dividend Yield

0.00%

Float4

13.40M

% Held by Insiders

0.03%

% Held by Institutions

82.26%

Balance Sheet

Total Cash(mrq)

185.47M

Total Cash Per Share(mrq)

11.63

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.42%

Quick Ratio(mrq)

7.23%

Book Value Per Share(mrq)

19.17

Cash Flow

Operating Cash Flow Per Share(ytd)

-11.73

Free Cash Flow(ytd)

-103.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement